Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Vaccines|August 6, 2021
Fusion Protein of Rotavirus VP6 and SARS-CoV-2 Receptor Binding Domain Induces T Cell ResponsesKirsi Tamminen, Suvi Heinimäki, Stina Gröhn, et al.
Journal of Immunology Research|April 24, 2018
Parenterally Administered Norovirus GII.4 Virus-Like Particle Vaccine Formulated with Aluminum Hydroxide or Monophosphoryl Lipid A Adjuvants Induces Systemic but Not Mucosal Immune Responses in MiceSuvi Heinimäki, Maria Malm, Timo Vesikari, et al.
Antiviral Research|June 24, 2018
Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4+ T lymphocytes with cytotoxic potentialSuvi Heinimäki, Maria Malm, Timo Vesikari, et al.
Virology|August 28, 2017
Live baculovirus acts as a strong B and T cell adjuvant for monomeric and oligomeric protein antigensSuvi Heinimäki, Kirsi Tamminen, Maria Malm, et al.
Journal of Immunology Research|May 16, 2020
Rotavirus VP6 Adjuvant Effect on Norovirus GII.4 Virus-Like Particle Uptake and Presentation by Bone Marrow-Derived Dendritic Cells In Vitro and In VivoKirsi Tamminen, Suvi Heinimäki, Timo Vesikari, et al.
Molecular Immunology|May 11, 2020
Internalization and antigen presentation by mouse dendritic cells of rotavirus VP6 preparations differing in nanostructureKirsi Tamminen, Suvi Heinimäki, Stina Gröhn, et al.
Archives of Virology|October 17, 2020
Expression of influenza A virus-derived peptides on a rotavirus VP6-based delivery platformStina Gröhn, Suvi Heinimäki, Kirsi Tamminen, et al.
Vaccine|December 17, 2017
Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypesMaria Malm, Kirsi Tamminen, Suvi Heinimäki, et al.
Vaccines|July 11, 2020
Rotavirus Inner Capsid VP6 Acts as an Adjuvant in Formulations with Particulate Antigens OnlySuvi Heinimäki, Kirsi Tamminen, Vesa P Hytönen, et al.
Virology|December 11, 2021
Antigenicity and immunogenicity of HA2 and M2e influenza virus antigens conjugated to norovirus-like, VP1 capsid-based particles by the SpyTag/SpyCatcher technologySuvi Heinimäki, Vili Lampinen, Kirsi Tamminen, et al.
Pageof 2